Ignite Creation Date:
2024-05-06 @ 1:38 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04084717
Status:
RECRUITING
Last Update Posted:
2023-06-18
First Post:
2019-09-08
Brief Title:
Study of Crizotinib for ROS1 and MET Activated Lung Cancer
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MET Amplification |
| Non-squamous Non-small-cell Lung Cancer |
| Stage IV Non-small Cell Lung Cancer |
| ROS1 Gene Rearrangement |
| MET Activating Mutation |
Keywords: